Company profile: Spindiag
1.1 - Company Overview
Company description
- Provider of an easy-to-use, compact, automated point-of-care PCR system for broad, fast, and affordable pathogen detection. The Rhonda player with Rhonda disks detects infectious agentsβincluding SARS-CoV-2, Influenza A/B, RSV, and MRSAβwith results in under one hour; the SARS-CoV-2 disk supports direct swab insertion. The Rhonda app displays results for mobile use, and test outcomes can be transferred directly into patient records.
Products and services
- Rhonda player: An automated PCR point-of-care analyzer used with Rhonda disks to detect infectious agents like SARSβCoVβ2, delivering underβoneβhour results with an easyβtoβuse, routineβcompatible workflow
- Rhonda Respi disk: A PCR-based test cartridge analyzing one patient swab for four viral pathogensβSARSβCoVβ2, Influenza A/B, and RSVβyielding underβoneβhour results when run on the Rhonda player
- Rhonda SARSβCoVβ2 disk: A cartridge-based PCR test allowing direct swab sample insertion into the Rhonda system, producing underβoneβhour SARSβCoVβ2 results for pointβofβcare diagnostics
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Spindiag
Health in Code
HQ: Spain
Website
- Description: Provider of genetic diagnosis and testing services for inherited diseases, with expertise in inherited cardiovascular conditions. Services include full NGS testing from DNA reception to specialized clinical reports, in-house sequencing kits with bioinformatics and variant database, variant interpretation per guidelines, multidisciplinary clinical genetic reports, specialist genetic counseling, and proteomics as a certified Olink Explore service provider.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Health in Code company profile β
Bluebird Bio
HQ: United States
Website
- Description: Provider of gene therapies for severe genetic and rare diseases, developing gene addition treatments that modify patient cells to address underlying genetic causes using lentiviral vectors. Products include LentiGlobin for sickle cell disease, Lenti-D for cerebral adrenoleukodystrophy, and Zynteglo for beta-thalassemia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Bluebird Bio company profile β
Genomic Vision
HQ: France
Website
- Description: Provider of novel genetic tests and research tools for life sciences, developed and commercialized using Molecular Combing, a proprietary single DNA molecule detection technology, combined with biomarker discovery; focused on DNA analysis and genetic testing in cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Genomic Vision company profile β
Athenix
HQ: United States
Website
- Description: Provider of crop science offerings in seeds, crop protection, and non-agricultural pest control, leveraging agricultural and industrial biotechnology and a gene-discovery infrastructure to develop products that meet real customer needs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Athenix company profile β
TissueGene
HQ: United States
Website
- Description: Provider of regenerative biopharmaceutical therapies for orthopedic disorders, offering TG-C, an allogeneic cell and gene therapy designed to treat knee osteoarthritis by reducing pain, improving function, and slowing disease progression.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full TissueGene company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Spindiag
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Spindiag
2.2 - Growth funds investing in similar companies to Spindiag
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Spindiag
4.2 - Public trading comparable groups for Spindiag
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β